2014 APIC Heroes
2014 APIC Heroes
Non-member price: 500.00
Member price: 0.00
0.00
You save 100.0%
Presentation 1#: "Plastic" Rounds: A Nurse-Centric Approach to Reducing Catheter-Associated Urinary Tract Infection (CAUTI) and Central Line-Associated Bloodstream Infection (CLABSI)Plastic Rounds is an innovative, nurse-led program that was created to help reduce infections associated with central lines and urinary catheters. Starting with nurses, the program provided education about proper use of central lines and urinary catheters, promoted critical thinking about the necessity of devices for each patient, and encouraged discussion with physicians when necessity was questioned. One key aspect to the program's success was the use of a Nursing best practice to achieve an Infection Prevention best practice. The program utilized a multi-disciplinary team representing infection prevention, nursing, educators, physicians, lean performance, database analysis, and the Quality Nurse Council , with executive sponsorship.Presentation 2#: Antimicrobial Stewardship: Defining the Role of the Infection Preventionist Inter-Professional CollaborationIn response to increasing rates of multidrug resistant organism (MDRO) infections at St. Joseph, Stephens worked with the ASP, Department of Infection Control, and Environmental Services (EVS) to develop institutional guidelines targeted at reducing carbapenem resistance and preventing environmental cross-contamination. This initiative included a three-tiered Patient Care Cleaning (PCC) program for all patient-care areas: direct, monthly observation of cleaning procedures; fluorescent markers applied to high-touch patient surface areas prior to terminal cleaning; and finally, patient-care service and equipment monitoring with ATP Bioluminescence. Monitoring was followed by education to all front-line EVS providers and management team members. In the four years following PCC implementation, the total number of Pseudomonas aeruginosa infections at St. Joseph Hospital decreased from 274 to 176 and the carbapenem susceptibility rate among patients with the microbe increased from 78 to 94 percent. Reduction in the total number of carbapenem-resistant infections resulted in approximately $1.1 million in total cost avoidance in 2013.
 
vProductThumbnailvProductTitlevProductCodevMemberPricevStandardPricevProductCategoryvProductStatusvProductKitvProductOtherDescription
https://apic.org/wp-content/uploads/2020/08/Webinar-Announcement-1.png2014 APIC HeroesWB-1512090.00500.00WEBINARSAFalse